<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> (LA) is an immunoglobulin directed towards the <z:chebi fb="0" ids="16247">phospholipid</z:chebi> portion of the prothrombin activator complex </plain></SENT>
<SENT sid="1" pm="."><plain>This immunoglobulin because first identified in the plasma of patients with Systemic <z:e sem="disease" ids="C0866588" disease_type="Disease or Syndrome" abbrv="">Lupus Erythematodes</z:e>, was named as <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Although initially described in patients with SLE, it was subsequently observed in other diseases and also in patients without any manifest disease </plain></SENT>
<SENT sid="3" pm="."><plain>SLE or similar diseases are present in 35% of LA (+) patients </plain></SENT>
<SENT sid="4" pm="."><plain>The LA prevalence in SLE patients has been found as 34% whereas ACA prevalence was found as 44% </plain></SENT>
<SENT sid="5" pm="."><plain>While searching for the presence of LA and the levels of <z:chebi fb="21" ids="53713">APA</z:chebi> in cases having unexplained recurrent fetal losses, a family (a mother and 3 daughters) was discovered, whose each member has been diagnosed as SLE at different times and with different symptoms </plain></SENT>
<SENT sid="6" pm="."><plain>Data suggesting the presence of LA and high <z:chebi fb="21" ids="53713">APA</z:chebi> levels were determined in <z:hpo ids='HP_0000001'>all</z:hpo> the members of the family and also it was realised that cause who had recurrent fetal losses had the highest <z:chebi fb="21" ids="53713">APA</z:chebi> levels </plain></SENT>
<SENT sid="7" pm="."><plain>In addition to immunoassay methods to detect <z:chebi fb="21" ids="53713">APA</z:chebi>, examination of coagulation tests in patients with unexplained <z:mp ids='MP_0005048'>thrombosis</z:mp> and/or fetal losses, would be of great help </plain></SENT>
</text></document>